Frequent Expression of the Variant CD30 in Human Malignant Myeloid and Lymphoid Neoplasms
- 31 December 1999
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 155 (6) , 2029-2041
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Tumor Necrosis Factor Receptor-associated Factor (TRAF) 5 and TRAF2 Are Involved in CD30-mediated NFκB ActivationJournal of Biological Chemistry, 1997
- CD30 ligand is expressed on resting normal and malignant human B lymphocytesBritish Journal of Haematology, 1996
- CD30 Contains Two Binding Sites with Different Specificities for Members of the Tumor Necrosis Factor Receptor-associated Factor Family of Signal Transducing ProteinsJournal of Biological Chemistry, 1996
- Antibodies specific for proteolyzed forms of protein kinase C αBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1995
- Activation of HIV expression by CD30 triggering in CD4+ T cells from HIV-infected individualsImmunity, 1995
- Cross-linking of CD30 induces HIV expression in chronically infected T cellsImmunity, 1995
- The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor familyCell, 1995
- mRNA translation: influence of the 5′ and 3′ untranslated regionsCurrent Opinion in Genetics & Development, 1994
- The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and deathCell, 1994
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992